Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Novel approach for vaccine delivery using mRNA lipid nanoparticles for <i>in vivo</i> production of monoclonal antibodies.

Molecular therapy. Nucleic acids·2026

Same author

The XEC Variant: Genomic Evolution, Immune Evasion, and Public Health Implications.

Viruses·2025

Same author

Methuselah proteins in Drosophila: Structural and evolutionary insights from mathematical genomics.

Biochemical and biophysical research communications·2025

Same author

Improved SARS-CoV-2 vaccine based on intranasally administered replicon RNA.

Molecular therapy : the journal of the American Society of Gene Therapy·2025

Same author

Viral Vector-Based Cancer Vaccines.

Methods in molecular biology (Clifton, N.J.)·2025

Same author

Immunobiology and immunotherapy of COVID-19.

Progress in molecular biology and translational science·2025

Search research articles

Related Experiment Video

Updated: Dec 8, 2025

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches

Published on: May 6, 2015

Alphavirus-Based Antigen Preparation.

Kenneth Lundstrom¹

¹PanTherapeutics, Lutry, Switzerland. lundstromkenneth@gmail.com.

Methods in Molecular Biology (Clifton, N.J.)

|September 22, 2020

Summary

This summary is machine-generated.

Alphavirus vectors efficiently express antigens for vaccines against diseases and tumors. These vectors, delivered via RNA, viral particles, or DNA, show promise in animal models, with limited human trials conducted.

Keywords:

Alphavirus vectors Cancer vaccines Immunization Protection against lethal challenges Viral vaccines

More Related Videos

Author Spotlight: Improved Method for Production and Purification of Adeno-Associated Viral Vectors

Author Spotlight: Improved Method for Production and Purification of Adeno-Associated Viral Vectors

Published on: April 5, 2024

Author Spotlight: Advancing Gene Therapy Research with High-Titer Adeno-Associated Virus Vector Production

Author Spotlight: Advancing Gene Therapy Research with High-Titer Adeno-Associated Virus Vector Production

Published on: May 3, 2024

Related Experiment Videos

Last Updated: Dec 8, 2025

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches

Published on: May 6, 2015

Author Spotlight: Improved Method for Production and Purification of Adeno-Associated Viral Vectors

Author Spotlight: Improved Method for Production and Purification of Adeno-Associated Viral Vectors

Published on: April 5, 2024

Author Spotlight: Advancing Gene Therapy Research with High-Titer Adeno-Associated Virus Vector Production

Author Spotlight: Advancing Gene Therapy Research with High-Titer Adeno-Associated Virus Vector Production

Published on: May 3, 2024

Area of Science:

Virology and Immunology
Vaccine Development

Background:

Alphavirus-based vectors offer a promising platform for antigen preparation in vaccine development.
Specific alphaviruses like Semliki Forest virus, Sindbis virus, and Venezuelan equine encephalitis virus have been engineered for antigen expression.

Purpose of the Study:

To review the application of alphavirus-based vectors for vaccine development.
To highlight the potential of these vectors in targeting infectious diseases and tumors.

Main Methods:

Engineering of alphaviruses for high-level antigen expression.
Delivery of alphavirus vectors as naked RNA replicons, recombinant viral particles, or DNA plasmids.
Evaluation of immunization efficacy in animal models.

Main Results:

Demonstrated protection against lethal doses of pathogenic infectious agents and tumor cells in animal models.
Versatile delivery methods (RNA, viral particles, DNA) enhance applicability.

Conclusions:

Alphavirus vectors are a powerful tool for vaccine development, showing significant potential in preclinical studies.
Further clinical trials are needed to fully assess the therapeutic potential in humans.